Best suited for | Strengths | Limitations | Toxicity | Onset, level, and duration of expressiona | Maximum insert size | Genome integration | |
---|---|---|---|---|---|---|---|
Electroporation | Cell types/tissues: Neuronal cell lines and freshly isolated primary neuronal cells in vitro; whole embryos in vivo Applications: Transfection of large numbers of robust cells in vitro (in suspension) or in vivo when high transfection efficiencies are required |
Simple and quick protocol, relatively little optimization required |
|
Variable depending on cell type and electroporation parameters used (robust cell types tend to survive the procedure better) | Typically within hours; expression levels variable depending on electroporation parameters used | No limit | No |
Nucleofection | Cell types: Neuronal cell lines and freshly isolated primary neuronal cells in vitro Applications:
|
|
|
Relatively low cell toxicity because of finely regulated sequences of voltage pulses and cell type-specific nucleofection solutions | Typically within hours; moderate expression rates, therefore possible to harvest cells up to several days after transfection to assess, for example, maximal downregulation of target proteins or long-term phenotypes | No limit | No |
Single cell electroporation | Cell types: Individual neuronal cells in vitro or in vivo, including mature, fully differentiated neurons Applications:
|
|
|
Moderate cell survival rate | Typically within hours; near physiological expression levels possible because physiological environment is maintained (depending on promoter used), therefore possible to image cells over months | No limit | No |
Ca2+-phosphate co-precipitation | Cell types: Neuronal cell lines; differentiating and mature (fully differentiated) primary neurons in vitro Applications:
|
|
|
Low (when crystal size and exposure time are optimized) | Typically within hours; depending on promoter and cell type: physiological expression levels within the first 12–18 h | No limit | No |
Lipofection | Cell types: Neuronal cell lines; differentiating and mature (fully differentiated) primary neurons in vitro (and in vivo following injection of transfection solution) Applications:
|
|
Relatively low efficiencies for post-mitotic neurons (typically ∼1–5%), but can go up to 30% after optimization | Adverse effects on neuronal morphology and/or viability have been reported (depending on cell type and reagent) | Typically within hours; moderate to nearly physiological expression depending on promoter and cell type | No limit | No |
Adenoviruses | Cell types: Cell lines and primary neuronal cells, including mature, fully differentiated neurons, in vitro; whole nervous system, including adult nervous system, in vivo Applications:
|
|
|
High when high virus titers are used | Onset after a few days; high levels of expression that can last for weeks to even months | ∼7.5 kb (high-capacity, helper-dependent AdVs: up to 34 kb) | No |
Adeno-associated viruses | Cell types: Cell lines and primary neuronal cells, including mature, fully differentiated neurons, in vitro; whole nervous system, including adult nervous system, in vivo Applications:
|
|
|
Low | Onset ∼2 weeks after transduction; high levels of expression | ∼5 kb | Yes |
Lentiviral vectors | Cell types: Cell lines and primary neuronal cells, including mature, fully differentiated neurons, in vitro; whole nervous system, including adult nervous system, in vivo Applications:
|
|
|
Low | Few hours after transduction; high levels of expression | ∼10 kb | Yes |
Herpes simplex viruses | Cell types: Cell lines and primary neuronal cells, including mature, fully differentiated neurons, in vitro; whole nervous system, including adult nervous system, in vivo Applications:
|
|
|
High; lower with amplicon vectors | Few hours after transduction; high levels of expression, decreases within the first few weeks | >100 kb possible (with amplicon vectors) | No |
Microinjection | Cell types: Large and robust neurons (neuronal cell lines; differentiating and mature primary neurons) in vitro Applications:
|
|
|
Poor survival rate because of physical damage of neurons during injection | Expression plasmids: typically within hours; fluorescent signal of injected labeled RNAs very low | No limit | No |
Biolistics | Cell types: All cell types in entire brains (in vivo) and tissue slices; cultured cells in vitro, including neuronal cell lines as well as differentiating and mature primary neurons (not suited for early differentiation stages however, as cells must be firmly adherent to substrate so as to not detach after bombardment with gold particles) Applications:
|
|
|
Significant cell damage caused by high pressure and accelerated gold particles; recently developed hand-held gene gun or use of ″mash″ show significant improvement | Typically within 1–2 d after bombardment; near-physiological expression generally persists for a minimum of 3–4 d in cell culture, up to 7 d in slices | No limit | No |
-
↵aIn addition to the parameters specific to each method, as described in this table, the onset, level, and duration of expression varies, e.g., with the plasmid and promoter used and the expressed construct, as well as the DNA concentration used.